![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | |
A61K 38/13 | |||
A61K 9/00 | |||
A61K 47/32 | |||
A61K 9/107 | |||
A61K 31/436 | |||
A61K 31/355 |
(11) | Number of the document | 2197461 |
(13) | Kind of document | T |
(96) | European patent application number | 08837729.6 |
Date of filing the European patent application | 2008-10-08 | |
(97) | Date of publication of the European application | 2010-06-23 |
(45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/079170 |
Date | 2008-10-08 |
(87) | Number | WO 2009/048929 |
Date | 2009-04-16 |
(30) | Number | Date | Country code |
997796 P | 2007-10-08 | US | |
992205 P | 2007-12-04 | US | |
38223 P | 2008-03-20 | US | |
99420 P | 2008-09-23 | US |
(72) |
MITRA, Ashim K., US
VALAGALETI, Poonam R., US
NATESAN, Subramanian, IN
|
(73) |
Aurinia Pharmaceuticals Inc.,
4464 Markham Street, Suite 1203, Victoria, BC V8Z 7X8,
CA
|
(54) | OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR MTOR INHIBITORS |
OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR MTOR INHIBITORS |